Research Center and Departments of Medicine, Université de Montréal and Montreal Heart Institute, 5000 Belanger Street, Montreal, Quebec, Canada.
Cardiovasc Res. 2011 Aug 1;91(3):420-8. doi: 10.1093/cvr/cvr082. Epub 2011 May 27.
Previous studies suggested that T-type Ca(2+)-current (I(CaT))-blockers improve cardiac remodelling, but all available I(CaT)-blockers have non-specific actions on other currents and/or functions. To clarify the role of I(CaT) in cardiac remodelling, we studied mice with either of the principal cardiac I(CaT)-subunits (Cav3.1 or Cav3.2) knocked out.
Adult male Cav3.1- or Cav3.2-knockout (Cav3.1(-/-), Cav3.2(-/-)) mice and respective wild-type (WT) littermate controls were subjected to left anterior descending coronary artery ligation to create myocardial infarction (MI). Echocardiography and programmed electrical stimulation were performed at baseline and 4 weeks post-MI. At baseline, Cav3.1(-/-) mice had slowed heart rates and longer PR intervals vs. WT, but no other electrophysiological and no haemodynamic differences. Cav3.2(-/-) showed no differences vs. WT. Contractile indices (left ventricular fractional shortening and ejection fraction) decreased more post-MI in Cav3.1(-/-) mice than in Cav3.1(+/+) (e.g. by 34 and 29% for WT; 50 and 45% for Cav3.1(-/-), respectively; P < 0.05 for each). Cav3.1(-/-) mice had increased ventricular tachycardia (VT) inducibility post-MI (9 of 11, 82%) vs. WT (3 of 10, 30%; P < 0.05). Cav3.2(-/-) mice were not different in cardiac function or VT inducibility vs. WT. Quantitative polymerase chain reaction showed that Cav3.1 is the major I(CaT)-subunit and that no compensatory Cav3.2 up-regulation occurs in Cav3.1(-/-) mice. Cav3.1(-/-) and Cav3.2(-/-) mice had no mRNA expression for the knocked-out gene, at baseline or post-MI.
Our findings suggest that, contrary to suggestions from previous studies with (imperfectly selective) pharmacological agents having T-type Ca(2+)-channel-blocking actions, elimination of Cav3.1 expression leads to impaired cardiac function and enhanced arrhythmia vulnerability post-MI, whereas Cav3.2 elimination has no effect.
先前的研究表明 T 型钙电流(ICaT)阻断剂可改善心脏重构,但所有可用的 ICaT 阻断剂对其他电流和/或功能均具有非特异性作用。为了阐明 ICaT 在心脏重构中的作用,我们研究了敲除主要心脏 ICaT 亚基(Cav3.1 或 Cav3.2)的小鼠。
成年雄性 Cav3.1 或 Cav3.2 敲除(Cav3.1(-/-)、Cav3.2(-/-))小鼠及其相应的野生型(WT)同窝对照小鼠接受左前降支冠状动脉结扎以建立心肌梗死(MI)。在基线和 MI 后 4 周进行超声心动图和程控电刺激。在基线时,与 WT 相比,Cav3.1(-/-) 小鼠心率较慢,PR 间期较长,但无其他电生理和血流动力学差异。Cav3.2(-/-) 与 WT 相比无差异。与 WT 相比,MI 后 Cav3.1(-/-) 小鼠的收缩指数(左心室短轴缩短率和射血分数)下降更多(例如,WT 分别下降 34%和 29%;Cav3.1(-/-) 分别下降 50%和 45%;每种情况 P < 0.05)。MI 后,Cav3.1(-/-) 小鼠的室性心动过速(VT)诱导率高于 WT(9/11,82%对 3/10,30%;P < 0.05)。与 WT 相比,Cav3.2(-/-) 小鼠的心脏功能或 VT 诱导率无差异。定量聚合酶链反应显示 Cav3.1 是主要的 ICaT 亚基,并且在 Cav3.1(-/-) 小鼠中没有发生 Cav3.2 的代偿性上调。Cav3.1(-/-) 和 Cav3.2(-/-) 小鼠在基线或 MI 后均未检测到敲除基因的 mRNA 表达。
与之前使用具有 T 型钙通道阻断作用的(不完全选择性)药理学药物的研究结果相反,我们的研究结果表明,Cav3.1 表达的消除导致 MI 后心功能受损和心律失常易感性增强,而 Cav3.2 的消除则没有影响。